References
- Australian Red Cross (2018) ‘Criteria for the clinical use of intravenous immunoglobulin in Australia’, Australian Red Cross, viewed 3 August 2018, https://transfusion.com.au/blood_products/fractionated_plasma/ivig.
- Berger, M., McCallus, D & Lin, C. (2013). ‘Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies’, Journal of the Peripheral Nervous System, Vol. 18, pp.275-296.
- Cats, E., van der Pol, W., Piepers, S., Franssen, H., Jacobs, B., van den Berg-Vos, R., Kuks, J., van Doorn, P., van Engelen, B., Verschuuren, J., Wokke, J., Veldink, J & van den Berg, L. (2010). ‘Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy’, American Academy of Neurology, Vol. 75, pp.818-825.
- Dimachkie, M., Barohn, J & Katz, J. (2013). ‘Multifocal Motor Neuropathy, Multifocal Acquired Demyelinating Sensory and Motor Neuropathy and Other Chronic Acquired Demyelinating Polyneuropathy Variants’, Neurologic Clinics, Vol. 31, No. 2: pp.533–555.
- Hahn, A., Beydoun, S., Lawson, V., Oh, M., Empson, V., Leibl, H., Ngo, Y., Gelmont, D & Koski, C. (2013). ‘A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy’, Journal of peripheral nervous system, Vol. 18, No. 4: pp.321-330.
- Jovanovich, E & Karam, C. (2015). ‘Human immune globulin infusion in the management of multifocal motor neuropathy’, Degenerative Neurological and Neuromuscular Disease, Vol. 2016, No. 6: pp.1-12.
- Katz, J., Lewis, R & Spatafora, D. (2017). ‘First Global Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey Identifies Needs in Education and Treatment’, Neurology, Vol.13, No. 16: pp. 1-15.
- Latov, N. (2014). ‘Diagnosis and treatment of chronic acquired demyelinating polyneuropathies’, NEUROLOGY, Vol. 10, pp.435-442.
- Lawson, V & Arnold, W. (2014). ‘Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment’, Neuropsychiatric Disease and Treatment, Vol. 10, pp.567-576.
- Léger, J., Guimarães-Costa, R & Iancu Ferfoglia, R. (2015). ‘The pathogenesis of multifocal motor neuropathy and an update on current management options’, Therapeutic Advances in Neurological Disorders, Vol. 8, No. 3: pp.109-122.
- Léger, J., Viala, K., Cancalon, F., Maisonobe, T., Gruwez, B., Waegemans, T & Bouche, P. (2008). ‘Intravenous immunoglobulin as short - and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients’, Journal of Neurology Neurosurgery Psychiatry, Vol. 79, pp.93-96.
- Meuth, S & Kleinschnitz, C. (2010). ‘Multifocal Motor Neuropathy: Update on Clinical Characteristics, Pathophysiological Concepts and Therapeutic Options’, European Neurology, Vol. 63, pp.193-204.
- Nobile-Orazio, E & Gallia, F. (2013). ‘Multifocal Motor Neuropathy: Current Therapies and Novel Strategies’, Drugs, Vol. 73, No. 5: pp.397-406.
- Nowacek, D & Teener, J. (2012). ‘Multifocal Motor Neuropathy’, Seminars in Neurology, Vol. 32, pp.500-505.
- Schaika, I., Boucheb, P., Illac, I., Le´gerb, J., Van den Berghd, P., Cornblathe, D., Eversf, E., Haddeng, R., Hughesh, R., Koskii, C., Nobile-Orazioj, E., Pollardk, J., Sommerl, C & van Doorn, P. (2006). ‘European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy’, European Journal of Neurology, Vol. 13, pp.802-808.
- Stangel, M., Gold, R., Pittrow, D., Baumann, U., Borte, M., Fasshauer, M., Hensel, M., Huscher, D., Reiser, M & Sommer, C. (2016). ‘Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry’, Therapeutic Advances in Neurological Disorders, Vol. 9, No. 3: pp.165–179.
- Sutedja, N. (2010). ‘Risk factors for motor neuron diseases, genes, environment and lifestyle’, Utrecht University, Rotterdam, The Netherlands.
- Vlam, L., Stam, M., Jager, W., Cats, E., van den Berg, L & van der Pol, W. (2015). ‘Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy’, Journal of Neuroimmunology, Vol. 286, pp.1-4.
- Yuki, N., Watanabe, H., Nakajima, T & Spath, P. (2010). ‘IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy’, Journal of Neurology Neurosurgery Psychiatry, Vol. 82, pp.87-91